269 results on '"Hansen, John‐Bjarne"'
Search Results
2. A genetic association study of circulating coagulation factor VIII and von Willebrand factor levels
3. The fatty liver index and risk of incident venous thromboembolism: the Tromsø Study
4. Extracellular vesicles from activated platelets possess a phospholipid-rich biomolecular profile and enhance prothrombinase activity
5. High microRNA-145 plasma levels are associated with decreased risk of future incident venous thromboembolism: the HUNT study
6. Optimized workflow to modify microRNA expression in primary human intravascular cells
7. Joint effect of ischemic stroke and obesity on the risk of venous thromboembolism: the Tromsø Study
8. Proportion of venous thromboembolism attributed to recognized prothrombotic genotypes in men and women
9. Comparison of assays measuring extracellular vesicle tissue factor in plasma samples: communication from the ISTH SSC Subcommittee on Vascular Biology
10. Combined effect of high factor VIII levels and high mean platelet volume on the risk of future incident venous thromboembolism
11. Plasma levels of P-selectin and future risk of incident venous thromboembolism
12. Survival after cancer-related venous thrombosis: the Scandinavian Thrombosis and Cancer Study
13. Hand grip strength in venous thromboembolism: risk of recurrence and mortality
14. Low D-dimer levels at diagnosis of venous thromboembolism are associated with reduced risk of recurrence: data from the TROLL registry
15. High plasma levels of C1-inhibitor are associated with lower risk of future venous thromboembolism
16. C1 inhibitor deficiency enhances contact pathway–mediated activation of coagulation and venous thrombosis
17. Venous thromboembolism and risk of depression: a population-based cohort study
18. Redefining clinical venous thromboembolism phenotypes: a novel approach using latent class analysis
19. Impact of the von Willebrand factor-ADAMTS-13 axis on the risk of future venous thromboembolism
20. Risk factors and predictors for venous thromboembolism in people with ischemic stroke: A systematic review
21. Joint effect of myocardial infarction and obesity on the risk of venous thromboembolism: The Tromsø Study
22. Elevated plasma levels of plasminogen activator inhibitor‐1 are associated with risk of future incident venous thromboembolism
23. Multi‐phenotype analyses of hemostatic traits with cardiovascular events reveal novel genetic associations
24. Plasma levels of platelet‐derived microvesicles are associated with risk of future venous thromboembolism
25. Rosuvastatin treatment decreases plasma procoagulant phospholipid activity after a VTE: A randomized controlled trial
26. A rapid, sensitive, and specific assay to measure TF activity based on chromogenic determination of thrombin generation
27. Estimated lifetime risk of venous thromboembolism in men and women in a Danish nationwide cohort: impact of competing risk of death
28. Plasma procoagulant phospholipid clotting time and venous thromboembolism risk
29. Socioeconomic status and risk of incident venous thromboembolism
30. Hemostatic factors, inflammatory markers, and risk of incident venous thromboembolism: The Multi‐Ethnic Study of Atherosclerosis
31. Plasma levels of von Willebrand factor and future risk of incident venous thromboembolism
32. Combined effects of five prothrombotic genotypes and cancer on the risk of a first venous thromboembolic event
33. Atrial fibrillation, venous thromboembolism, ischemic stroke, and all‐cause mortality: The Tromsø study
34. Myocardial infarction, prothrombotic genotypes, and venous thrombosis risk: The Tromsø Study
35. Impact of respiratory symptoms and oxygen saturation on the risk of incident venous thromboembolism—the Tromsø study
36. Cardiorespiratory fitness and future risk of venous thromboembolism
37. Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism
38. Plasma levels of mannose‐binding lectin and future risk of venous thromboembolism
39. Impact of prothrombotic genotypes on the association between family history of myocardial infarction and venous thromboembolism
40. Physical activity and risk of recurrence and mortality after incident venous thromboembolism
41. Complement activation assessed by the plasma terminal complement complex and future risk of venous thromboembolism
42. Effect of prothrombotic genotypes on the risk of venous thromboembolism in patients with and without ischemic stroke. The Tromsø Study
43. Dietary intake of marine n‐3 polyunsaturated fatty acids and future risk of venous thromboembolism
44. The Risk of Incident Venous Thromboembolism Attributed to Overweight and Obesity: The Tromsø Study.
45. The association between red cell distribution width and venous thromboembolism is not explained by myocardial infarction, stroke, or cancer
46. Acute infection as a trigger for incident venous thromboembolism: Results from a population‐based case‐crossover study
47. Myocardial infarction and future risk of cancer in the general population—the Tromsø Study
48. Time trends in incidence rates of venous thromboembolism in a large cohort recruited from the general population
49. C-reactive protein in atherosclerosis – A risk marker but not a causal factor? A 13-year population-based longitudinal study: The Tromsø study
50. Risk of a permanent work-related disability pension after incident venous thromboembolism in Denmark: A population-based cohort study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.